Cargando…
Recent advances in the molecular prognostication of meningiomas
Meningiomas are the most common primary intracranial neoplasm. While traditionally viewed as benign, meningiomas are associated with significant patient morbidity, and certain meningioma subgroups display more aggressive and malignant behavior with higher rates of recurrence. Historically, the risk...
Autores principales: | Wang, Elaina J., Haddad, Alexander F., Young, Jacob S., Morshed, Ramin A., Wu, Joshua P. H., Salha, Diana M., Butowski, Nicholas, Aghi, Manish K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845914/ https://www.ncbi.nlm.nih.gov/pubmed/36686824 http://dx.doi.org/10.3389/fonc.2022.910199 |
Ejemplares similares
-
CDK 4/6 inhibitors for the treatment of meningioma
por: Young, Jacob S., et al.
Publicado: (2022) -
WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
por: Haddad, Alexander F., et al.
Publicado: (2020) -
Recent Advances in Meningioma Immunogenetics
por: Al-Rashed, May, et al.
Publicado: (2020) -
Novel intraoperative strategies for enhancing tumor control: Future directions
por: Haddad, Alexander F, et al.
Publicado: (2022) -
Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives
por: Takase, Hajime, et al.
Publicado: (2022)